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Neuronal cell migrationShp2 is a non-receptor protein tyrosine phosphatase containing two Src homology 2 (SH2) domains that is
implicated in intracellular signaling events controlling cell proliferation, differentiation and migration. To
examine the role of Shp2 in brain development, we created mice with Shp2 selectively deleted in neural
stem/progenitor cells. Homozygous mutant mice exhibited early postnatal lethality with defects in neural
stem cell self-renewal and neuronal/glial cell fate speciﬁcation. Here we report a critical role of Shp2 in
guiding neuronal cell migration in the cerebellum. In homozygous mutants, we observed reduced and less
foliated cerebellum, ectopic presence of external granule cells and mispositioned Purkinje cells, a phenotype
very similar to that of mutant mice lacking either SDF-1α or CXCR4. Consistently, Shp2-deﬁcient granule
cells failed to migrate toward SDF-1α in an in vitro cell migration assay, and SDF-1α treatment triggered a
robust induction of tyrosyl phosphorylation on Shp2. Together, these results suggest that although Shp2 is
involved in multiple signaling events during brain development, a prominent role of the phosphatase is to
mediate SDF-1α/CXCR4 signal in guiding cerebellar granule cell migration.
© 2009 Elsevier Inc. All rights reserved.IntroductionThe development of cortical structures in mammalian central
nervous system (CNS) is characterized by a concerted process of
neuronal differentiation, migration and consequent assembly into
compact neuronal cell layers (Hatten, 1999; Herrup and Kuemerle,
1997). Whereas the radial glial ﬁbers serve as a scaffold, local
environmental cues provide the critical information in orchestrating
directed movement of neurons in the developing brain (Hatten,
2002). It has been widely recognized that speciﬁc components of
extracellular matrices (ECM), cytokines, and chemokines act to
coordinate neuronal migration events, and much of our knowledge
in this regard has been contributed by phenotypic analyses of classical
and gene-targeted mouse mutants with defects in brain development
(Gupta et al., 2002; Hatten, 1999). However, relatively little is known
about the speciﬁc cytoplasmic components linking various neuronal
migration pathways and, so far, only fragmented experimental dataCSD School of Medicine, 9500
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operate in this process.
Several groupshave shown that the chemokine stromal cell-derived
factor 1α (SDF-1α) binds to its receptor CXCR4 to control neuronal cell
migration in the cerebellum (Ma et al., 1998; Zhu et al., 2002; Zou et al.,
1998). The CXCR4-deﬁcient mice die perinatally and exhibit disturbed
external germinal layer (EGL), ectopically positionedPurkinje cells, and
many chromophilic cell clumps within the cerebellar anlage. Interest-
ingly, mice deﬁcient for either SDF-1α or CXCR4 display an almost
identical phenotype in the cerebellum, suggesting an unusual mono-
gamous relationship between a ligand and a receptor in orchestrating
cerebellar development (Ma et al., 1998).
Shp2, a Src homology 2 (SH2)-containing protein tyrosine
phosphatase, is a widely expressed intracellular enzyme (Lai et al.,
2004; Neel et al., 2003). Although Shp2 has been implicated in several
signaling pathways, compelling evidence from in vitro and in vivo
studies strongly suggest a critical role of Shp2 in control of cell
migration during animal development. A targeted deletion of exon 3,
encoding 65 amino acids in the SH2-N domain of murine Shp2
(Shp2Δ46–110), results in embryonic lethality in homozygotes, with
abnormalities in the patterning, particularly a posterior truncation, of
mesodermal structures due to cell migration defect (Saxton et al.,
1997). Chimeric animal analysis with homozygous Shp2Δ46–110
mutant embryonic stem (ES) cells identiﬁed an Shp2 function in
guiding morphogenetic cell movement during gastrulation and also in
limb development (Qu et al., 1998; Saxton et al., 2000; Saxton and
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blast (MEF) cells are defective inmigration in vitro, throughmodulation
of focal adhesion kinase (Fak) activity and cytoskeletal reorganization
(Oh et al., 1999; Saxton and Pawson, 1999; Yu et al., 1998).
In most recent studies, we generated a mutant mouse model with
Shp2 selectively deleted in neural stem/progenitor cells (Ke et al.,
2007). The conditional Shp2 knockout mice exhibited growth
retardation and early postnatal lethality, with multiple defects
observed in neuronal migration and differentiation in cerebral and
cerebellar cortices, particularly a migration defect of granule cells in
the cerebellum. In this communication, we present experimental data
suggesting that Shp2 is a critical signal transducer downstream of
SDF-1α/CXCR4 in guiding granule cell migration during cerebellar
development.
Materials and methods
Animals
Mice were maintained in the animal facility of Burnham Institute
for Medical Research in accordance with NIH guidelines and approved
by the Institute's animal research committee. Generation of a
conditional Shp2 mutant allele (Shp2ﬂox) was reported previously
(Zhang et al., 2004). Generation and characterization of Shp2ﬂox/ﬂox:
nestin-Cre transgenic mice were described elsewhere (Isaka et al.,
1999; Ke et al., 2007).
Reagents and antibodies
Anti-GFAPmonoclonal antibody (G3893) and anti-calbindinmono-
clonal antibody (C9848) were from Sigma. Rabbit anti-neuroﬁlament
Mantibody (AB1987)was fromChemicon. Rabbit anti-L1 antibodywas
a generous gift from Dr. Stallcup (Burnham). Monoclonal antibodies
against nestin, TAG-1, and RC2 were from DSHB, University of Iowa.
Rabbit anti-SH-PTP2 (Shp2) (C-18) antibody (sc-280) and anti-PCNA
antibody (sc-7907)were from Santa Cruz Biotechnology. Anti-p27kip1
(AHZ0452) and anti-Cyclin D1 (AHF0102) antibodies were from
Biosource. Fluorophore-labelled secondary antibodies were purchased
from Molecular Probes. Antibodies to phospho-p44/42 Erk (pThr202/
pTyr204, #9101), phospho-SHP-2 (pTyr542, #3751), FAK (#3285),
phospho-FAK (pTyr925, #3284), and phospho-FAK (pTyr576/577,
#3281) were purchased from Cell Signaling. Rabbit anti-Erk1/2
antibody was generated in our own laboratory. NRG1-1α, BDNF, NT-
4/5, and SDF-1α were purchased from PeproTech Inc.
Immunohistochemistry
Immunochemical staining of brain sections was performed
following standard protocols. Parafﬁn sections were heated in 55 °C
oven for 30 min, deparafﬁnized, hydrated in ethanol, washed in DW,
immersed in boiled citrate buffer for 30 min, washed in PBS, blocked
in PBS with 5% normal goat serum (or normal donkey serum) and 1%
Triton X-100, incubated with primary antibody, washed, and
incubated with secondary antibody from Molecular Probes. After
washing, they were mounted using a Dapi or PI mounting solution
(Vector). Envision system, HRP (DAKO) was used as a solution of
secondary antibody for DAB staining.
Tissue culture
The cerebellumwas removed from E16.5 and P1mice, incubated in
a solution of papain or trypsin with DNase for 5 min at room
temperature, titrated in a solution of DNase using a ﬁre-polished glass
pipette. Fibroblasts were removed by incubation in DMEM with 10%
FBS for 20min at 37 °C. Then the cells were incubated for 2 h at 37 °C to
allow glial cells attachment on culture plates. Attached glial cells wereincubated in DMEM with 10% FBS. The medium was replaced with
DMEM without FBS overnight before stimulation (NRG: 50 ng/ml or
10 nM). The supernatant containing neurons was incubated for 4 h at
37 °C so neurons were attached on cover glasses or culture dishes
coated with poly-D-lysine or poly-DL-ornithine plus laminin. The
medium was replaced with a neurobasal medium with B27 (Gibco).
Isolated cells were incubated in a 10%O2 and 5% CO2 incubator at 37 °C.
The neurons were starved in the neurobasal medium without B27 for
4 h before growth factor stimulation (BDNF, 10 ng/ml; SDF-1α,
100 ng/ml).
Granule cell axon extension assays
Granule cells from P1 mice were cultured with growth factors
(BDNF, 10 ng/ml; NT4/5, 10 ng/ml; SDF-1α, 100 ng/ml) for 3 days.
The growth factors were added to culture medium every day. Cells
were ﬁxed and stained with anti-neuroﬁlament M antibody, and the
neurite length was measured under a microscope.
In vivo cell proliferation assay
5-Bromo-2′-deoxy-uridine (BrdU) labelling and detection kit I
(Roche) was used to measure cell proliferation. For cerebellum, BrdU
was intraperitoneally injected into P1 mice (20 μl/g BW) under
anesthesia. After 1 h, the brain was removed, ﬁxed in 4% PFA/PBS.
Sections at size of 5 μm were cut using the cryostat. Brain sections
were post-ﬁxed in 4% PFA/PBS for 5min, washed, incubated in 2 NHCl
for 20 min, washed in PBS, incubated in 0.2% Triton X-100/PBS for
20 min, 0.1 M boric acid for 20 min, washed, and processed following
the manufacturer's protocol.
Cerebellar explant assay for external granule cell migration
Granule cell migration was measured in vitro as previously
described (Zhu et al., 2002), with slight modiﬁcation. Embryonic
brain at E16.5 or 17.5 was taken out and put in L-15 media
(Invitrogen) on ice. The forebrain was isolated, and then the
cerebellar meninge was removed from the ventral side. Cerebellum
was taken out from the brainstem in L-15 medium under a dissection
microscope, and put in L-15 medium on ice until it was chopped. The
cerebellum was transferred to the top of the tissue chopper using a
top cut 1000 μl pipette tip, and the excess mediumwas sucked off. The
cerebellum was cut sagitally at thickness of 200 μm. The pieces of the
chopped cerebellumwerewashed out in L-15medium and kept on ice
until use. The external granular layer (EGL) was cut out from the
pieces in L-15 medium under a dissection microscope using a tip bent
tungsten needle which was ﬁned in 0.5 N NaOH electrically, and the
rest part was discarded. Then the EGL was cut into small rectangles as
the layer side was longer, and were kept on ice until use.
Gel A was made from the mixture of 9 μl of 10×DMEM, 85 μl of
collagen gel (BD Science) diluted 1:1 by 0.1×DMEM, and 1 μl of 1 N
NaOH, and kept on ice. Gel B was made by adding gel A to 60 μl of
matrigel (BD Science) and 30 μl of DMEM with 10% FBS and 1%
penicillin–streptomycin, and kept on ice. All reagents were kept on
ice, and 45 μl of gel A and 5 μl of SDF-1α (100 ng/μl) or PBS (as control
solution) were mixed, and then 5 μl of the mixture was put in a 30-
mm culture dish. The top was ﬂatted with a pipette tip, and the
mixture was left at room temperature for 5 min to be solidiﬁed. The
prepared EGLs were transferred around the gel using a 200-μl pipette,
and the excess medium was sucked off. Gel B (30 μl) was added
around the gel, and the EGLs were organized around the gel so that
the shorter side faced to the gel in the distance of approximately 200–
300 μm using the tungsten needle. After the gel was kept at room
temperature for 30 min, the dishes were put in a 5% CO2 incubator for
30min so that the gel was solidiﬁed. Then 2ml of DMEMwith 10% FBS
and 1% penicillin–streptomycin was added into the dishes. After 3-day
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the dishes, and the dishes were incubated at room temperature for
1 h, washed with PBS 3× for 20 min each, and mounted using Dapi
mounting solution (Vector). Pictures were taken and the number of
migratory cells on the proximal (P) and distal (D) sides was counted,
and the P/D ratios were calculated. Statistical analyses were carried
out using Student's t test.
Results
Shp2 expression in cerebellum
We and others have previously shown that Shp2 is widely
expressed in all cell types, as compared to another SH2-containing
tyrosine phosphatase Shp1 whose expression is restricted to
hematopoietic and epithelial cells (Feng and Pawson, 1994; Neel,
1993). In this study, we examined Shp2 expression proﬁles in the
cerebellum in early postnatal and adult mice. In the early postnatal
cerebellum, Shp2 expression was detected at high levels in the cell
body of granule cells and ﬁbers of the external granular layer (EGL) at
P4 (Figs. 1A–C). Strong expression of Shp2 was also recognized in
some large cells just below EGL at P4 (the inset of Fig. 1A). Next, we
tried to identify the cells and ﬁbers by double-staining with calbindin,
a marker of Purkinje cells, and RC2, a marker of Bergmann radial glia.
While calbindin-positive cells overlappedwith Shp2-positive Purkinje
cells, there were a number of large Shp2-positive cells below the
calbindin-positive Purkinje cells (Fig. 1B). RC2-positive cells and
ﬁbers overlapped Shp2-positive cells and ﬁbers in most parts
(Fig. 1C). Therefore, we conclude that the Shp2-positive cells below
the Purkinje cells were Bergmann radial glia. At P10, Shp2 expression
was recognized in parallel ﬁbers in the molecular layer (ML), andFig. 1. Shp2 expression in cerebellum. (A) Immunostaining of Shp2 in developing cerebellum
cerebellum. The inset showed a higher magniﬁcation of large cells expressing Shp2 strongly,
cells. Scattered staining was also present in the internal granule layer, scale bar: 100 μm. At P1
molecular layer; PCL, Purkinje cell layer; IGL, internal granule layer. (B) At P4, Shp2 (green)
below calbindin+ Purkinje cells, scale bar: 50 μm; EGL, external granule layer; PCL, Purkinje
parts, scale bar: 50 μm; EGL, external granule layer; PCL, Purkinje cell layer.weaker staining was found in the cell body of granule cells in the
internal granular layer (IGL) (Fig. 1A). At P15, the EGL disappeared
and strong staining was recognized on parallel ﬁbers from granule
cells in ML (Fig. 1A). Shp2 expression was also found in the cytoplasm
of Purkinje cells (Fig. 1A).
Aberrant granule cell migration in cerebellum
To conditionally delete Shp2 in the brain, we crossed Shp2ﬂoxed
(Shp2F)micewithnestin-cre transgenicmice, as describedpreviously (Ke
et al., 2007). The resultant homozygous mutant mice (Shp2F/F:Cre/+)
displayed early postnatal lethality and defects in corticogenesis, and
reduced proliferation of progenitor cells in the ventricular zone. In
vitro analysis of stem/progenitor cells isolated from E14.5 embryonic
brain demonstrated a critical role of Shp2 in mediating basic
ﬁbroblast growth factor (bFGF) signals for self-renewing proliferation
of neural stem cells (Ke et al., 2007).
In this study, we focused our attention on examining the
consequence of Shp2 deletion in cerebellar development and
observed less foliation and substantial decrease in size in mutant
cerebellum at P10. The medial-sagittal section analysis of Shp2F/F:Cre
brain at P10 indicated that the cerebellar volume was reduced as
compared to the controls (Fig. 2A), with more mutant external
granule cells already migrated inward than the controls at P4
(Fig. 2B). One remarkable abnormality in the mutants was the
existenceof a thinner anddisorganizedmolecular layer,ML (Fig. 2A). As
evaluated by TUNEL assay, there was no signiﬁcant difference in
apoptotic cell numbers between control andmutant cerebella (data not
shown). Thus, the reduced size of mutant cerebella is not due to
increased cell apoptosis, but is more likely associated with defects in
axonextensionand inBergmannglia formation (see theResults below).. At P4, the staining was in the external granular layer and the strong staining was inside
scale bar: 50 μm. At P10, strong expression was in the ML and the cytoplasm of Purkinje
5, the staining was mainly in theML, scale bar: 100 μm; EGL, external granule layer; ML,
was expressed in calbindin+ Purkinje cells (red), Shp2-positive cells were also present
cell layer. (C) At P4, RC2+ Bergmann glia (red) overlapped Shp2+ cells (red) in most
Fig. 2. Developmental defects in the cerebellum. (A) H&E staining at P10. Note that the mutant (MUT) lobes were smaller and the mutant cerebellum had a remarkably thinner ML
than the control (CTL). Abnormal cell streaks were present in the mutant. Scale bar: 100 μm. (B) H&E staining at P4. Note that many external granule cells already migrated inward
from the EGL andwere present within the Purkinje layer in themutant (MUT) cerebellum (arrows). Scale bar: 25 μm. (C) TAG-1 expression (green) at P4. TAG-1 was expressed in the
inner part of EGL in the control (CTL). Almost no TAG-1 expression was found in the whole mutant cerebellum. Scale bar: 50 μm. (D) The expression of PCNA (green) and p27kip1
(red) at P10. PCNA staining was found in the outer part of EGL, while p27kip1 expression was present in the inner part of EGL and internal granular layer in the control (CTL). Ectopic
PCNA staining (arrows) was recognized in the deep inside of the mutant (MUT) cerebellum. Scale bar: 100 μm. (E) Cyclin D1 expression at P6. The expression was present in the
outer part of EGL in the control (CTL). Abnormal rosette-like staining was recognized in the deep inside of the mutant (MUT) cerebellum. Scale bar: 50 μm. (F) BrdU incorporation
assay. The ratio was BrdU+ external granular cell number divided by external granular cell number. (n=3, PN0.05).
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assessed expression of TAG-1, a marker for postmitotic and pre-
migratory granule cells in the inner external granular layer (Furley
et al., 1990). The expression intensity decreased in almost the whole
folia in the mutants at P4, while clearly maintained in control
littermates at this stage (Fig. 2C). This result suggests a delay in
differentiation of external granule cells in Shp2 mutants. Next, we
evaluated PCNA and p27kip1 expression to identify proliferative
external granule cells, postmitotic external, and internal granule
cells. PCNA is expressed in the outer EGL, related to the S phase in cell
cycle, while p27kip1, a cyclin-dependent protein kinase inhibitor, is
expressed in the inner EGL and internal granule layer (IGL)
(Miyazawa et al., 2000). Surprisingly, PCNA+ granule cells were
ectopically and intensively recognized in the cerebellum of mutant
mice at P10 (Fig. 2D). To verify this observation, expression of cyclin
D1, a cell cycle marker, was examined at P6. A similar abnormal
staining pattern as PCNA was recognized in the mutants as well(Fig. 2E). To investigate whether the PCNA+ cells are simply due to an
increase in cell proliferation, BrdU incorporation assay was performed
at P1. A similar number of BrdU+ external granule cells were detected
in mutants and controls (Fig. 2F), suggesting that ectopic presence of
external granule cells is not due to increased proliferation, but rather a
migration problem, in the mutant cerebellum.
A critical role of Shp2 in the SDF-1α/CXCR4 pathway
The premature inward migration pattern of external granule cells
was very similar to the cerebellar phenotype observed in mice lacking
SDF-1α or its receptor CXCR4 (Ma et al., 1998; Zou et al., 1998),
suggesting a possibly essential role of Shp2 in the SDF-1α/CXCR4
pathway. It was recently reported that over-expression of Shp2 in
primary T lymphocytes enhanced CXCR4-mediated cell migration
(Hoff and Brunner-Weinzierl, 2007). We performed cerebellar
explant assay for determination of external granule cell migration
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quantitated as described elsewhere (Zhu et al., 1999). Brieﬂy, the
area surrounding each explant was divided into four quadrants
(Fig. 3A). The number of cells in the quadrant proximal (P) to a
potential source of guidance (SDF-1α) was compared to that in the
distal (D) quadrant. Whereas the control external granule cells
extensively migrated toward the gel containing SDF-1α, Shp2-
deﬁcient cells exhibited reduced motility toward SDF-1α (Fig. 3B).
The P/D ratio of cell number was signiﬁcantly higher in control
explants than that in the mutants (Fig. 3C).
To obtain direct biochemical evidence for Shp2 involvement in
SDF-1α /CXCR4 signaling, we examined phosphorylation status of
Shp2 on Tyr542 residue following SDF-1α stimulation of cerebellar
neurons. A phosphonate at Tyr542 was reported to interact intramole-
cularly with the N-terminal SH2 domain to relieve basal inhibition of
the PTPase (Lu et al., 2001). Treatment of neuronal cells with SDF-1α
for 10 or 20 min induced robust phosphorylation of Shp2 on Tyr542,
suggesting that Shp2 is indeed a player downstream of SDF-1α/CXCR4
(Fig. 3D). The next question iswhether Shp2 ablation disrupts SDF-1α-
elicited cytoplasmic signaling events downstreamof CXCR4. To address
this issue, we assessed phospho-Erk signals in control and mutant
cerebellar granule cells. As shown in Fig. 3E, SDF-1α-stimulated
phospho-Erk1/2 levels were attenuated in mutant cerebellar neurons
as compared to controls, suggesting a requirement for Shp2 in
transmitting/amplifying cytoplasmic signals elicited by SDF-1α.Fig. 3. Deletion of Shp2 inhibits granule cell response to SDF-1α. (A) A diagram showing the ar
Representativepictures of control andmutantEGL explants. Control cellsmigrated toward theg
of the cell numbermigrated into theproximal (P) anddistal (D) areas to the gelwas calculated.
(D) p-Shp2 (Tyr542) levelswere determined in P0 cerebellar neurons following stimulation of
to SDF-1α (100 ng/ml) in P1 cerebellar neurons. The signals were quantiﬁed by NIH image. P
(4146). Erk1/2: C0 (6600); C10 (5080); C20 (4796); M0 (5821); M10 (6642); and M20 (5900
(0.02); M10 (0.87); and M20 (0.70). (F) p-FAK (Tyr925) and p-FAK (Tyr576/577) levels were mTo decipher the biochemical mechanism by which Shp2 modulates
SDF-1α-stimulated granule cell migration, we examined the effect of
Shp2 ablation onphosphorylation levels of focal adhesion kinase (FAK),
a critical player in control of neuronal cell motility (Li et al., 2004; Liu
et al., 2004; Ren et al., 2004). As shown in Fig. 3F, SDF-1α induced
signiﬁcant increase of FAK tyrosine phosphorylation on Tyr925 and
Tyr576/577, as detected by site-speciﬁc anti-phosphotyrosine anti-
bodies. Interestingly, deletion of Shp2 resulted in constitutive tyrosine
phosphorylation of FAK on these sites in the absence of SDF-1α
stimulation, thereby disrupting the cycling of FAK between unphos-
phorylated and phosphorylated forms. It is believed that inactivation of
FAK is required for reactivation of this kinase in orchestrating the
dynamic assembly of signalsomes controlling cell motility (Cohen and
Guan, 2005; Yu et al., 1998).
Reduced axon extension of granule neurons
To determine the cellular basis for the thin molecular layer in
mutant cerebellum, we examined parallel ﬁbers of granule cells in the
ML at P10 using the L1 marker (Stallcup et al., 1985). Proper
organization of the ML was disrupted especially in the rostral part,
and the L1 expression was detected in granule cell bodies rather than
in parallel ﬁbers in themutants (Fig. 4A), suggesting a defect in axonal
extension of granule cells. When measured in vitro, the mutant axons
were obviously shorter than the control, consistent to the immuno-ea of quadrants around each explant. P, the proximal quadrant; D, the distal quadrant. (B)
el of SDF-1α, whilemutant cells exhibiteddefect in directedmovement. (C) The ratio (P/D)
Themeans and SEMof the controls (n=28)and themutant (n=29)were shown,Pb0.01.
SDF-1α (100 ng/ml) for 0, 10 and20min. (E) p-Erk1/2 signalswere evaluated in response
hospho-Erk1/2: C0 (3463); C10 (12538); C20 (10062); M0 (145); M10 (5747); and M20
). The ratios (Phospho-Erk1/2 divided by Erk1/2): C0 (0.52); C10 (2.47); C20 (2.10); M0
easured after SDF-1α stimulation (100 ng/ml) in P1 cerebellar neurons.
Fig. 4. Defects in axon extension of granule cells. (A) L1 expression at P10. L1 expression (red) was present in the ML in the control (CTL). The section was counterstained with Dapi
(Blue). Abnormal L1 staining was recognized in cell bodies of the deep rostral cerebellum in the mutant. The molecular layer stained by L1 was not evident in the mutant rostral
cerebellum. L1 expression was absent in a part of the mutant caudal cerebellum. Scale bar: 100 μm. (B) Granule cells at P1 were cultured for 3 days, ﬁxed, and stained with anti-
neuroﬁlamentM antibody. The neurite lengthwasmeasured; blue, control; red, mutant. (C) The control granule cells from P1were cultured for 3 dayswith BDNF (10 ng/ml), NT-4/5
(10 ng/ml), or SDF-1α (100 ng/ml), ﬁxed, and stained with anti-neuroﬁlament M antibody. The neurite length was measured. Blue, no stimulation; red, BDNF; yellow, NT-4/5, and
light blue, SDF-1α. The distribution of the neurite length sifted to right in response to all stimuli. (D) Themutant granule cells from P1were cultured, stimulatedwith BDNF, NT-4/5 or
SDF-1α, and the neurite length was measured as in C. (E) The p-Erk1/2 levels were measured in response to BDNF (10 ng/ml) in P1 cerebellar neurons.
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282 K. Hagihara et al. / Developmental Biology 334 (2009) 276–284histochemical data (Fig. 4B). We further examined granule cell axon
extension under the treatment of SDF-1α, BDNF and NT-4/5, as
described previously (Arakawa et al., 2003; Gao et al., 1995). While
control granule cells extended neurites in response to BDNF, NT-4/5
and SDF-1α, mutant cells displayed much reduced capacity (Figs. 4C
and D). Therefore, the thinner and disorganized molecular layer is
evidently contributed by a defect in axonal extension of granule cells.
Consistent with the defective axon extension, BDNF-induced
phospho-Erk1/2 signals were evidently reduced in Shp2-deﬁcient
cerebellar neurons (Fig. 4E), similar to the reduction in phospho-Erk
levels following SDF-1α stimulation (Fig. 3E).
The external granule cells migrate inward and Purkinje cells move
upward along the radial glia (Hatten, 1999). To explore another
possibility that may account for their abnormal migration, we
examined the formation of radial glia by assessing GFAP expression,
a radial glial marker (Hoser et al., 2007; Lordkipanidze and
Dunaevsky, 2005; Wiencken-Barger et al., 2007), on cerebellar
sections at P6 and P10. The normal direction of radial glia was
disrupted in themutant and the end of the processes did not extend to
the pial surface (Figs. 5A and B). On the same sections, Purkinje cells
were stained with an anti-calbindin antibody. As shown in Figs. 5A
and B, Purkinje cells formed a monolayer in the control, but they were
not properly positioned in themutant cerebellum, exhibitingmultiple
layers. We also examined Bergmann glia formation at an earlier stage,
P4, using another marker, nestin (Allais et al., 2007; Andrae et al.,
2001), and found that the formation of Bergmann glia was
disorganized at the early stage in mutant cerebella (Fig. 5C).
It is known that treatment with neuregulin (NRG) potently
transforms astrocytes into radial glia (Pinkas-Kramarski et al., 1994;
Rio et al., 1997). In addition, previous in vitro experimental data
suggested a role of Shp2 downstream of neuregulin (NRG) receptor, a
member of the ErbB family (Tanowitz et al., 1999). We examined the
effect of Shp2 deletion on NRG signaling. The phospho-Erk1/2 levels
were remarkably reduced in mutant glia compared to controls
following NRG stimulation (Fig. 5D). Together, our results show thatFig. 5. Abnormal glial development and molecular signaling in the cerebellum. (A) The Be
formed multiple layers in the mutant (MUT) at P6. Scale bar: 100 μm. (B) A high magniﬁca
already disorganized in the early stage at P4 in themutant (MUT). Scale bar: 50 μm. (D) The p
the cerebellum.Shp2 plays critical roles in cerebellar development by modulating
signals elicited by SDF-1α and other cytokines. Multiple develop-
mental problems exist in Shp2F/F:nestin-cre cerebellum, with a distinct
phenotype of granule cell migration defect indicating an Shp2
function in the SDF-1α/CXCR4 pathway.
Discussion
In this study, we ﬁrst examined Shp2 expression in developing
cerebellum in wild-type mice. The results presented here are largely
consistent with previous data published by us and other groups (Feng
et al., 1993; Servidei et al., 1998). Shp2 is well known as a widely
expressed enzyme in different cell types, in contrast to its close
relative Shp1 that is predominantly expressed in hematopoietic,
lymphocytic and epithelial cells (Feng and Pawson, 1994). In the
central nervous system, high levels of Shp2 expression were detected
in actively dividing neural progenitor cells, consistent results were
obtained by several groups in vitro and in vivo (Gauthier et al., 2007;
Ke et al., 2007; Servidei et al., 1998). We report here that Shp2
expression is rich in external granule cells, Purkinje cells, axons of
internal granule cells, and Bergmann glia in cerebellum. The minor
difference between our data shown here and that of Servidei et al.
might be explained by different antibodies used by the two groups:
Servidei et al. used an antibody against the SH2-N domain of Shp2
(Servidei et al., 1998), while our antibody was raised against the C-
terminal part of Shp2 protein. The 3-dimensional structure of Shp2 is
changed between the catalytically active and inactive forms, which
may affect the reactivity with an antibody recognizing the SH2-N
domain (Neel et al., 2003; Fernandis et al., 2004).
Conditional deletion of Shp2 directed by nestin-cre leads to a
dramatic phenotype of early postnatal lethality, apparently due to
multiple defects in the brain (Ke et al., 2007). This mouse model has
allowed for demonstration of Shp2 functions in self-renewing
proliferation of neural stem cells and also in neuronal/glial fate
speciﬁcation from progenitor cells (Ke et al., 2007). Reeves' grouprgmann glia (GFAP, green) were disorganized, and the Purkinje cells (calbindin, red)
tion at P10 similar to (A). Scale bar: 50 μm. (C) The Bergmann glia (nestin, red) were
-Erk1/2 levels weremeasured following stimulation of neuregulin (10 nM) in the glia of
283K. Hagihara et al. / Developmental Biology 334 (2009) 276–284generated a transgenic mouse line expressing a catalytically inactive
mutant of Shp2 under control of a nestin promoter sequence (Aoki
et al., 2000). However, the transgenic mice were viable, appeared to
develop normally, and did not show any obvious histological
abnormalities in the embryonic and adult brain except for increased
susceptibility to ischemia-induced brain damage (Aoki et al., 2000).
This mild phenotype of transgenic mice suggests that expression of
the Shp2 mutant did not efﬁciently suppress the activities of
endogenous Shp2 enzyme.
In examining cerebellar development, we found that PCNA+
granule cells were ectopically located below the EGL, apparently due
to premature inward migration of EGL cells. This cerebellar
phenotype is remarkably similar to that of both SDF-1α and
CXCR4 knockout mice (Ma et al., 1998; Zou et al., 1998), suggesting
a severe interference or disruption of the SDF-1α/CXCR4 pathway in
the Shp2-deﬁcient brain. To establish and extend this point, we
directly measured SDF-1α-induced granule cell motility using
cerebellar explants derived in an in vitro cell movement assay
(Zhu et al., 2002). Indeed, we detected signiﬁcantly reduced
migration capability of Shp2-deﬁcient granule cells in response to
SDF-1α stimulation, as compared to control cells. The phenotype of
altered granule cell migration in vivo and in vitro identiﬁes Shp2 as
an essential player in transmitting/amplifying signals downstream
of CXCR4. In support of the biological role of Shp2 for SDF-1α/
CXCR4 signaling, we obtained biochemical evidence that SDF-1α
treatment induced robust tyrosine phosphorylation of Shp2 in wild-
type granule cells. Deletion of Shp2 resulted in suppression of SDF-1α-
induced phospho-Erk signal.
FAK as one of key players in promoting cell migration was
phosphorylated on tyrosine in control cells upon SDF-1α stimulation.
Shp2 ablation leads to constitutive increase of FAK phosphorylation,
and this observation is consistent to our previous data obtained in
Shp2-deﬁcient mouse embryonic ﬁbroblast cells (Yu et al., 1998),
which strongly suggests a critical role of Shp2 in control of reversible
FAK phosphorylation necessary for promotion of cell migration. The
action of FAK in promoting cell motility requires its cycling between
phosphorylation and dephosphorylation, correlating with its activa-
tion, inactivation and reactivation. Therefore, one biochemical
mechanism for Shp2 action downstream of SDF-1α/CXCR4 is likely
to control the turnover of FAK in guiding cell migration. In mutant
mice, p-Erk signals were remarkably reduced after BDNF stimulation.
However, it is evident that deletion of Shp2 affected multiple
signaling pathways in cerebellar development. Another interesting
phenotype we observed is the disorganization of radial glia in the
mutant cerebellum. External granule cells migrate inward and
Purkinje cells climb out from ventricular zone partly using Bergmann
radial glia in cerebellum (Hatten, 1999). In Shp2 mutants, dis-
organized radial glia formation may have also contributed to ectopic
presence of granule cells and mispositioning of Purkinje cells. To
further determine the molecular and cellular basis for the premature
granule cell migration phenotype, it will be necessary to create
another mouse model in which Shp2 is deleted in granule cells only,
by crossing Shp2 ﬂoxed mice with Math1-cre transgenic mice. It is
also worthwhile to note that the molecular layer is much thinner in
mutant than in control cerebella, whichmight be amajor contributing
factor to the reduced size of the mutant cerebellum. Consistent with
the thin molecular layer, mutant cerebellar internal granule cells
exhibited reduced capability of extending their axons in vitro, in
response to SDF-1α, BDNF and NT-4/5 stimulation. Thus, Shp2 also
participates in axonal outgrowth through modulation of signals
triggered by SDF-1α, BDNF and NT-4/5. Consistently, previous
experiments suggest that Shp2 acts downstream of TrkB, the receptor
of BDNF and NT-4/5 (Bibel and Barde, 2000). Furthermore, an effect of
Shp2 deletion on granule cell differentiation as shown by reduced
TAG-1 expression may also contribute to the defective granule cell
migration phenotype.In summary, combined genetic and biochemical data support a
notion that Shp2 is a key player in relay of SDF-1α/CXCR4 signals in
orchestrating granule cell migration during cerebellar development,
although this observation does not exclude Shp2 involvement in other
signaling events guiding cell movement. Shp2 was also shown to
participate in the pathway of CXCR4-mediated chemotaxis and
chemoinvasion in breast cancer cells (Fernandis et al., 2004). Shp2
was implicated in differentiation and apoptosis of primary T
lymphocytes (Hoff and Brunner-Weinzierl, 2007). On a separate
project, we have obtained experimental results suggesting a role of
Shp2 in mediating SDF-1 signals in B lymphocytes (our unpublished
data). Thus, the Shp2 function in mediating SDF-1/CXCR4-guided cell
migration pathway appears to be conserved in a variety of cell types in
mammals. Furthermore, phenotypic analysis of mutant embryos with
homozygous deletion of exon 3 in Ptpn11/Shp2 identiﬁed a severe
defect in mesodermal cell migration, resulting in a posterior
truncation (Saxton et al., 1997). Generation of chimeric animals by
injecting exon 3−/− embryonic stem cells into wild-type embryos
revealed a role of Shp2 in morphogenic movement at gastrulation,
supporting a notion that Shp2 is required for a chemotactic response
to signals initiated by ﬁbroblast growth factors (Saxton and Pawson,
1999). Together, these results establish a role of Shp2 inmodulation of
intracellular signals guiding cell motility in mammals.
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